Evidence map›Paper›PMID 30401777›Full record

ArticlemBio2018

Yang Mi, Rajendra Kumar Gurumurthy, Piotr K Zadora, Thomas F Meyer, Cindrilla Chumduri

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Microorganisms · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Exploiting bacteria for cancer immunotherapy.Nature reviews. Clinical oncology · 2024
    Review
  9. Review
  10. Mycoplasma DnaK expression increases cancer development in vivo upon DNA damage.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Review
  12. Article
  13. Microorganisms · 2023
    Review
  14. Article
  15. Bacteria-Cancer Interface: Awaiting the Perfect Storm.Pathogens (Basel, Switzerland) · 2021
    Review
  16. Review
  17. Journal of Cancer · 2021
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Yang Mi *Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Rajendra Kumar Gurumurthy *Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Piotr K ZadoraDepartment of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Thomas F MeyerDepartment of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.ORCID 0000-0002-6120-8679
Cindrilla ChumduriDepartment of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany tfm@mpiib-berlin.mpg.de.
Max Planck Institute for Infection Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical and ovarian cancers exhibit characteristic mutational signatures that are reminiscent of mutational processes, including defective homologous recombination (HR) repair. How these mutational processes are initiated during carcinogenesis is largely unclear.

Indexed as

DNA Breaks, Double-StrandedRecombinational DNA RepairSignal TransductionAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineChlamydia trachomatisHEK293 CellsHeLa CellsHumansPhosphorylationProtein Interaction MappingProtein Phosphatase 2Ataxia Telangiectasia Mutated ProteinsCell Cycle ProteinsPPP2CA protein, humanProtein Phosphatase 2ATMDNA damage responseDNA double-strand breakshomologous recombination repairinfectionPP2A

Identifiers

PMID30401777
PMCPMC6222135
OpenAlexW2897021259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.